SCHEMBL4920722

SCHEMBL4920722

CCCN1Cc2nc3c(-c4cc(OC)cc(OC)c4)cccc3c(N)c2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ HRH4 Q9H3N8 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ CRHR1 P34998 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ PARP2 Q9UGN5 1/20 0.35
▸ ENPP1 P22413 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ ADORA1 P30542 2/20 0.34
▸ FGFR1 P11362 1/20 0.34
▸ FGFR2 P21802 1/20 0.34
▸ FGFR4 P22455 1/20 0.34
▸ FGFR3 P22607 1/20 0.34
▸ ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2661560 0.93 BRD4 (0.40) KDM4EALDH1A1TSHRHRH4MAPT
SCHEMBL2661141 0.92 PDE5A (0.40) KDM4EALDH1A1TSHRHRH4MAPT
SCHEMBL4919239 0.91 KDM4E (0.37) KDM4EALDH1A1TSHRHRH4MAPT
SCHEMBL4923490 0.89 KDM4E (0.38) KDM4EALDH1A1MAPTLMNATP53
SCHEMBL2661065 0.89 ALDH1A1 (0.40) KDM4EALDH1A1TSHRHRH4MAPT
SCHEMBL2656723 0.87 GABRG2 (0.44) KDM4EALDH1A1CRHR1MEN1KMT2A
SCHEMBL4925336 0.87 HRH4 (0.40) KDM4EALDH1A1HRH4ENPP1ADORA1
SCHEMBL4924170 0.87 TP53 (0.42) KDM4EALDH1A1TSHRHRH4MAPT
SCHEMBL4921370 0.86 PDE5A (0.37) HRH4CRHR1ENPP1ADORA1ADORA2A
SCHEMBL4920872 0.86 CRHR1 (0.47) KDM4EALDH1A1TSHRMAPTCRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US claimed
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318943-A1 Compounds and Uses Thereof - 848 COMT, BACE1, BDNF KDM4E 2357/4885ALDH1A1 442/4885TSHR 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback